Cargando…
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer. Large-scale metabolomic data have associated metabolic alterations with the pathogenesis and progression of renal carcinoma and have correlated mitochondrial activity with poor survival in a subset of pat...
Autores principales: | Rupert, Christofer, Dell’ Aversana, Carmela, Mosca, Laura, Montanaro, Vittorino, Arcaniolo, Davide, De Sio, Marco, Bilancio, Antonio, Altucci, Lucia, Palinski, Wulf, Pili, Roberto, de Nigris, Filomena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214673/ https://www.ncbi.nlm.nih.gov/pubmed/37231503 http://dx.doi.org/10.1186/s13046-023-02713-1 |
Ejemplares similares
-
Combination of Genomic Landsscape and 3D Culture Functional Assays Bridges Sarcoma Phenotype to Target and Immunotherapy
por: de Nigris, Filomena, et al.
Publicado: (2023) -
miRNA-mediated deregulation in leukemia
por: Dell’Aversana, Carmela, et al.
Publicado: (2012) -
Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients
por: Palinski, Wulf, et al.
Publicado: (2021) -
Cancer epigenetics: Moving forward
por: Nebbioso, Angela, et al.
Publicado: (2018) -
Breast Cancer Vaccines: New Insights
por: Benedetti, Rosaria, et al.
Publicado: (2017)